ABSTRACT
I. INTRODUCTION Chapter 19 (1) addressed antibodies to interferon-a (IFN-a) developed in patients treated with either natural or recombinant IFN-a products. This chapter presents data on antibodies generated in multiple sclerosis (MS) patients on IFN-p therapy.
